What WRIGHT MEDICAL GROUP INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Andrews Julie | VP Fin. & Chief Acctg. Officer | Oct 01 | Disposition to Issuer · D | −14,506 | — | — | 0 |
| Palmisano Robert J | President and CEO | Oct 01 | Disposition to Issuer · D | −146,431 | — | — | 0 |
| Berry Lance A | Sr. VP & CFO | Oct 01 | Disposition to Issuer · D | −66,704 | — | — | 0 |
| Emerson Martin J | Director | Oct 01 | Disposition to Issuer · D | −28,280 | — | — | 0 |
| Blackford Gary | Director | Oct 01 | Disposition to Issuer · D | −54,700 | — | — | 0 |
| Hamilton Lawrence W | Director | Oct 01 | Disposition to Issuer · D | −28,280 | — | — | 0 |
| Girin Pascal E R | EVP & Chief Operating Officer | Oct 01 | Disposition to Issuer · D | −39,162 | — | — | 0 |
| Stevens David D | Director | Oct 01 | Disposition to Issuer · D | −64,959 | — | — | 0 |
| Paul Amy S | Director | Oct 01 | Disposition to Issuer · D | −29,700 | — | — | 0 |
| Tracey Julie D | SVP & Chief Commun. Officer | Oct 01 | Disposition to Issuer · D | −12,090 | — | — | 0 |
| Miclot John L | Director | Oct 01 | Disposition to Issuer · D | −28,280 | — | — | 0 |
| Walker Jennifer S. | SVP - Process Improvement | Oct 01 | Disposition to Issuer · D | −36,846 | — | — | 0 |
| Watson Douglas G | Director | Oct 01 | Disposition to Issuer · D | −31,688 | — | — | 0 |
| Labrum Ronald K | Director | Oct 01 | Disposition to Issuer · D | −18,142 | — | — | 0 |
| Lightman James | SVP, General Counsel & Secty | Oct 01 | Disposition to Issuer · D | −19,927 | — | — | 0 |
| Quillinan Robert J | Director | Oct 01 | Disposition to Issuer · D | −28,280 | — | — | 0 |
| Griffin William L. Jr | SVP GM BioMimetic Therapeutics | Oct 01 | Disposition to Issuer · D | −68,995 | — | — | 0 |
| Cordell Kevin D | President, U.S. Extremities | Oct 01 | Disposition to Issuer · D | −7,472 | — | — | 0 |
| Senner Jason R. | SVP, Chief HR Officer | Oct 01 | Disposition to Issuer · D | −3,546 | — | — | 0 |
| Cooke Peter | President, International | Oct 01 | Disposition to Issuer · D | −7,033 | — | — | 0 |
Loading...
